Policy & Legal, Research

FDA Action on Aspartame Unlikely

Ira S. Loss, Executive Vice President & Health Care Analyst
Ryan Visnovec, Research Assistant
12 July 2023

Summary

Recent reports that the World Health Organization (WHO) will reclassify aspartame as “possibly carcinogenic to humans” on July 14 has once again thrust questions about the safety of the additive into the spotlight. We believe it is highly unlikely the FDA will do anything to alter its status on the Generally Recognized as Safe (GRAS) list.


Want to learn more? Download the Report.

Solutions

Public Policy & Legal Research
Identify opportunity and risk driven by public policy and the courts.

Related Insights

Mitigation Expectations for Medicare Advantage Rate Notice

Mitigation Expectations for Medicare Advantage Rate Notice

Size of Medicare Advantage mitigation may be less than earlier expectations...
Read more